| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.34B | 36.80B | 34.18B | 31.21B | 29.52B | 26.95B |
| Gross Profit | 27.18B | 26.81B | 24.93B | 22.53B | 21.48B | 19.73B |
| EBITDA | 12.33B | 12.07B | 7.08B | 8.03B | 8.28B | 10.99B |
| Net Income | 7.31B | 7.16B | 3.12B | 6.14B | 2.28B | 5.26B |
Balance Sheet | ||||||
| Total Assets | 73.46B | 70.33B | 74.12B | 68.33B | 72.16B | 71.17B |
| Cash, Cash Equivalents and Short-Term Investments | 10.04B | 9.77B | 11.24B | 11.28B | 9.86B | 11.66B |
| Total Debt | 0.00 | 8.07B | 10.65B | 8.79B | 13.09B | 15.15B |
| Total Liabilities | 28.10B | 25.11B | 28.31B | 24.93B | 29.31B | 29.65B |
| Stockholders Equity | 44.86B | 44.73B | 45.44B | 43.16B | 40.13B | 38.85B |
Cash Flow | ||||||
| Free Cash Flow | 8.06B | 7.94B | 4.42B | 5.55B | 4.77B | 5.52B |
| Operating Cash Flow | 8.86B | 8.65B | 5.22B | 6.33B | 5.65B | 6.22B |
| Investing Cash Flow | -283.02M | -1.33B | -667.00M | 906.00M | 667.00M | -3.06B |
| Financing Cash Flow | -9.93B | -7.85B | -3.40B | -7.73B | -6.34B | -56.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $199.19B | 22.29 | 17.25% | 1.07% | 14.77% | 41.36% | |
73 Outperform | $107.44B | 50.22 | 22.20% | 0.64% | 17.21% | 43.17% | |
71 Outperform | $144.41B | 27.05 | 12.37% | 0.63% | 9.58% | 21.99% | |
69 Neutral | $31.46B | 66.22 | 7.97% | ― | 13.28% | 31.76% | |
67 Neutral | $91.07B | 57.69 | 14.98% | ― | 21.72% | 13.59% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | $47.18B | -48.84 | -60.27% | ― | 29.16% | -2.26% |